PROCYSBI (Horizon Pharma Inc.)
Welcome to the PulseAid listing for the PROCYSBI drug offered from Horizon Pharma Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Horizon Pharma Inc. |
| NON-PROPRIETARY NAME: | Cysteamine bitartrate |
| SUBSTANCE NAME: | CYSTEAMINE BITARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, DELAYED RELEASE PELLETS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-04-30 |
| END MARKETING DATE: | 0000-00-00 |
PROCYSBI HUMAN PRESCRIPTION DRUG Details:
| Item Description | PROCYSBI from Horizon Pharma Inc. |
| LABELER NAME: | Horizon Pharma Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2013-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 75987-100_4a275d2d-2b7c-49c8-b1ca-68604b962db2 |
| PRODUCT NDC: | 75987-100 |
| APPLICATION NUMBER: | NDA203389 |
Other CYSTEAMINE BITARTRATE Pharmaceutical Manufacturers / Labelers:
